Emmanouil Chatiras

Sort Bio

Manos Chatiras was born in Athens on 03-08-1977. He is a recognized executive with proven know-how and business experience with significant financial success in London and New York. His experience in building new business ideas in multinational organizations gives him invaluable knowledge of how international companies operate. Today he is the Chairman, CEO & Co-Founder of Curity Pharma S.A. He has over 15 years of experience in investment management and financial experience. From 2009 to 2019 he excels at Deutsche Bank in London. He started his career at Deutsche Bank as Head of Hedge Fund Research and Investments at Corporate & Investment Bank. In 2013 he transferred to fund management division of Deutsche Bank as the Global Head of Hedge Funds. Since 2016 he has been the Managing Director - Global Head of Multi-Asset Products, at the Corporate & Investment Bank of Deutsche Bank and a Member of the Executive Committee of Global Investment Solutions. Under Mr. Chatiras' leadership, his team was directly responsible for managing $12 billion and had been repeatedly recognized as the Best Overall Investment Platform. Prior to joining Deutsche Bank, he was Credit Agricole's Head of European Equity Research and a member of Credit Agricole's Investment Committee. He began his professional career in 2004 in New York as a hedge fund analyst at Lyra Capital LLC. During his financial career he was involved in most markets including the IT market having analyzed Hedge Funds investments in the IT field. He is the author of academic and practical articles with papers published by Wiley Publications as well as The Journal of Alternative Investments. He holds an MBA from the University of Massachusetts in the USA and a bachelor's degree in Economics and IT company management from the University of Maine in the USA where he graduated with distinction.